Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 100 shares at $30.25 ($3K) on 2021-09-09, disclosed to the SEC on 2021-09-10.
Scheduled sale ($3k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |